erytech

About:

ERYtech Pharma is a biopharmaceutical company, develops enzyme-based medicinal products for the oncology, hematology and immunology sectors.

Website: http://www.erytech.com

Twitter/X: erytech_pharma

Top Investors: Andera Partners, Bpifrance, Societe Generale, New Enterprise Associates, Ardian

Description:

ERYtech Pharma specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. It has achieved a major breakthrough in the fields of cancer and enzyme therapy by significantly increasing the therapeutic index of the encapsulated molecule or enzyme.

Total Funding Amount:

$228M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Lyon, Rhone-Alpes, France

Founded Date:

2004-01-01

Contact Email:

contact(AT)erytech.com

Founders:

Yann Godfrin

Number of Employees:

101-250

Last Funding Date:

2021-12-13

IPO Status:

Public

Industries:

© 2025 bioDAO.ai